Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
2(29%)
Results Posted
0%(0 trials)
Terminated
2(29%)

Phase Distribution

Ph phase_2
1
14%
Ph not_applicable
4
57%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(2)
Terminated(2)
Other(1)

Detailed Status

Completed2
Terminated2
Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (20.0%)
N/A4 (80.0%)

Trials by Status

unknown114%
completed229%
terminated229%
recruiting229%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
OTHER
Total Trials
7